Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease

AstraZeneca20,000 enrolled

Overview

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

Study Type

OBSERVATIONAL

Enrollment

20,000

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010

Research Site

Uppsala, Sweden

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

Time frame: Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

To map out the development of asthma and COPD treatment in Iceland after the change in reimbursement

Time frame: Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

To investigate health economic outcomes

Time frame: Data will be extracted from the medical records and registries on one occassion, covering a period of 3 years

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.